PTP1B Protein

A collaboration between Dr. Nilesh Banavali of the Wadsworth Center’s Division of Genetics and a multidisciplinary team led by Dr. Benoit Boivin at the University at Albany’s Department of Nanoscale Science and Engineering has resulted in a publication in Redox Biology. 

The study explores a peptide-based strategy to restore the activity of protein tyrosine phosphatase 1B (PTP1B), which can be inactivated by a regulatory protein in some cancers.  The researchers developed a peptide that disrupts this interaction, restoring PTP1B activity and suppressing cancer cell growth.  Dr. Banavali contributed computational molecular-modeling expertise to the research team. 

The findings provide scientific proof of principle for a potential therapeutic strategy and demonstrate the value of Wadsworth’s molecular-modeling expertise in developing new approaches to improve health outcomes.  The work also highlights the impact of productive collaborations between Wadsworth Center scientists and academic partners.  

More News